On November 23, 2022, the Office of the U.S. Trade Representative (USTR) announced the further extension of exclusions for numerous products used to combat COVID-19 that are subject to China Section 301 tariffs. The exclusions were scheduled to expire on November 30, 2022, and have been extended for an additional 90 days, until February 28, 2023. The exclusions cover 81 medical care products and were initially granted on December 29, 2020.
For more details on past China Section 301 tariff exclusion extensions for COVID-19 products, see Update of May 27, 2022.